Wysong, A., A. . Somani, . S. Ibrahim, J. . Cañueto, A. . Fitzgerald, J. . Siegel, A. Prasai, M. Goldberg, A. Farberg, J. . Kasprzak, D. . Brodland, S. Koyfman, and S. . Arron. “Incorporating the 40-Gene Expression Profile (40-GEP) Test Within Each Clinicopathologic Staging System Improves Metastatic Risk-Stratification in Patients Diagnosed With Cutaneous Squamous Cell Carcinoma (cSCC) and One or More High Risk Factors”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 1, Jan. 2024, p. s334, doi:10.25251/skin.8.supp.334.